zacks.com / .zacks-com / Page 3

Dillard's (DDS) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Cimpress (CMPR) is well positioned to outperform the market, as it exhibits above-average growth in financials.

TTM (TTMI) could produce exceptional returns because of its solid growth attributes.

ATI (ATI) possesses solid growth attributes, which could help it handily outperform the market.

Palantir Technologies (PLTR) could produce exceptional returns because of its solid growth attributes.

Select Medical and Carilion Clinic plan a 50-bed rehab hospital in Virginia as demand continues to grow.

ESLT heads into Q1 2026 earnings with rising defense demand, a record backlog and a new UAV acquisition boosting its global reach.

STERIS' Healthcare and AST segments post solid gains and milestones, but FX volatility, tariffs and global macro pressures threaten earnings variability.

Medtronic eyes a $650 million acquisition of SPR, adding the FDA-cleared SPRINT PNS System to expand its chronic pain treatment offerings ahead of the fiscal 2027 closing.

Warner Music Group Corp. (WMG) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.